0001497649 false 2023 --09-30 Q2 Yes 0001497649 2022-10-01 2023-03-31 0001497649 2023-08-04 0001497649 2023-03-31 0001497649 2022-09-30 0001497649 2023-01-01 2023-03-31 0001497649 2022-01-01 2022-03-31 0001497649 2021-10-01 2022-03-31 0001497649 us-gaap:CommonStockMember 2022-09-30 0001497649 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001497649 GSTX:StockReceivableMember 2022-09-30 0001497649 us-gaap:RetainedEarningsMember 2022-09-30 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001497649 us-gaap:CommonStockMember 2022-10-01 2022-12-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2022-10-01 2022-12-31 0001497649 GSTX:StockReceivableMember 2022-10-01 2022-12-31 0001497649 us-gaap:RetainedEarningsMember 2022-10-01 2022-12-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-10-01 2022-12-31 0001497649 2022-10-01 2022-12-31 0001497649 us-gaap:CommonStockMember 2022-12-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001497649 GSTX:StockReceivableMember 2022-12-31 0001497649 us-gaap:RetainedEarningsMember 2022-12-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001497649 2022-12-31 0001497649 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001497649 GSTX:StockReceivableMember 2023-01-01 2023-03-31 0001497649 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001497649 us-gaap:CommonStockMember 2023-03-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001497649 GSTX:StockReceivableMember 2023-03-31 0001497649 us-gaap:RetainedEarningsMember 2023-03-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001497649 us-gaap:CommonStockMember 2021-09-30 0001497649 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001497649 GSTX:StockReceivableMember 2021-09-30 0001497649 us-gaap:RetainedEarningsMember 2021-09-30 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001497649 2021-09-30 0001497649 us-gaap:CommonStockMember 2021-10-01 2021-12-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2021-10-01 2021-12-31 0001497649 GSTX:StockReceivableMember 2021-10-01 2021-12-31 0001497649 us-gaap:RetainedEarningsMember 2021-10-01 2021-12-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-10-01 2021-12-31 0001497649 2021-10-01 2021-12-31 0001497649 us-gaap:CommonStockMember 2021-12-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001497649 GSTX:StockReceivableMember 2021-12-31 0001497649 us-gaap:RetainedEarningsMember 2021-12-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001497649 2021-12-31 0001497649 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001497649 GSTX:StockReceivableMember 2022-01-01 2022-03-31 0001497649 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001497649 us-gaap:CommonStockMember 2022-03-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001497649 GSTX:StockReceivableMember 2022-03-31 0001497649 us-gaap:RetainedEarningsMember 2022-03-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001497649 2022-03-31 0001497649 2010-06-21 2023-03-31 0001497649 2023-03-30 0001497649 2022-03-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

 

FORM 10-Q

 

☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the quarterly period ended March 31, 2023

 

☐ Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period from __________ to __________

 

Commission File Number: 333-174194

  

GRAPHENE & SOLAR TECHNOLOGIES LTD
(Exact name of registrant as specified in its charter)

 

colorado   27-2888719
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)

 

23 Corporate Plaza Drive, Suite 150

Newport Beach, CA 92660

(Address of principal executive offices, including Zip Code)

 

(949) 478-8387 

(Issuer’s telephone number, including area code) 

(formally known as Solar Quartz Technologies Corporation) 

(Former name or former address if changed since last report)

 

Check whether the issuer (1) filed all reports required to be filed by section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☐ No ☒

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a small reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “non-accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated Filer ☐ Accelerated Filer ☐
Non-accelerated filer ☐ Smaller reporting company ☒
    Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

As of August 4, 2023, the registrant had 384,792,610 outstanding shares of common stock.

1

 

 

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

 

FORM 10-Q

 

TABLE OF CONTENTS

 

 

PART I — FINANCIAL INFORMATION  
Item 1. Condensed Consolidated Balance Sheets (Unaudited) 3
Item 2. Condensed Consolidated Statements of Operations (Unaudited) 4
Item 3. Condensed Consolidated Statements of Changes in Stockholders’ Deficiency (Unaudited) 5
Item 4. Condensed Consolidated Statements of Cash Flows (Unaudited) 7
Item 5. Management’s Discussion and Analysis of Financial Condition and Results of Operations. 12
Item 6. Controls and Procedures. 16
     
PART II — OTHER INFORMATION 18
Item 1 Legal Proceedings 18
Item 1A Risk Factors 18
Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 18
Item 3 Defaults on Senior Securities 18
Item 4 Mine Safety Disclosures 18
Item 5 Other Information 18
Item 6. Exhibits. 18
     
SIGNATURES 19

 

 

2

 

 

 

 

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

CONDENSED CONSOLIDATED BALANCE SHEETS

 

       
   March 31, 2023  September 30,
   (Unaudited)  2022
Assets          
Current Assets:          
Cash  $10,349   $2,857 
Prepaid expenses   11,545    11,183 
Total Current Assets   21,894    14,040 
Other Assets:          
Furniture and equipment, net of depreciation $79,916   1,144    1,273 
Intellectual property – at cost, net   1    —   
Other intangible assets – at cost   975    975 
Other receivable   4,015    2,094 
Total Assets  $28,029   $18,382 
           
Liabilities and Stockholders’ Deficit          
Current Liabilities:          
Accounts payable and other payable  $2,489,799   $2,380,565 
Accrued interest payable   171,736    161,602 
Due to related parties   1,576,084    1,342,405 
Notes payable – in default   60,000    76,255 
Convertible notes payable, net of discount $0 and $100,747 in default   100,747    100,747 
Notes payable – Related Party   41,892    —   
Total Current Liabilities   4,440,258    4,061,574 
           
Total Liabilities  $4,440,258   $4,061,574 
           
Stockholders’ Deficit:          
Preferred stock: 10,000,000 shares authorized; $0.00001 par value; no shares issued and outstanding   —      —   
Common stock: 500,000,000 shares authorized; $0.00001 par value; 374,542,610 and 374,305,480 shares issued and outstanding   3,751    3,748 
Additional paid-in capital   63,592,721    63,527,513 
Accumulated deficit   (67,446,375)   (67,070,016)
Stock Receivable   (795,000)   (795,000)
Accumulated other comprehensive income   232,674    290,563 
Total Stockholders’ Deficit   (4,412,229)   (4,043,192)
           
Total Liabilities and Stockholders’ Deficit  $28,029   $18,382 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 

3

 

 

   

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE
INCOME

(Unaudited)

 

             
   Three Months Ending March 31,  Six Months Ending March 31,
   2023  2022  2023  2022
             
Revenues  $—     $—     $—     $—   
                     
Operating expenses                    
Professional Services   153,253    172,282    288,107    12,726,455 
General and administrative   11,847    269,782    54,638    550,456 
Total operating expenses   165,100    442,064    342,745    13,276,911 
                     
Loss from operations   (165,431)   (442,064)   (342,745)   (13,276,911)
                     
Other income (expense)                    
Other income   10,662    6,594    16,962    11,276 
Interest expense   (5,022)   (4,835)   (10,135)   (25,428)
Loss on extinguishment of debt   (40,441)   —      (40,441)   —   
Total other income (expense)   (34,801)   1,759    (33,614)   (14,152)
                     
Net Income (Loss)  $(199,901)  $(440,305)  $(376,359)  $(13,291,063)
                     
Other Comprehensive Income  $16,566   $(47,456)  $(57,889)  $(56,702)
                     
Net Comprehensive Loss  $(183,335)  $(487,761)  $(434,248)  $(13,347,765)
                     
Income (Loss) per share:                    
Basic and diluted  $(0.00)  $(0.00)  $(0.00)  $(0.04)
                     
Weighted average shares outstanding   374,310,750    362,823,733    374,308,086    360,019,487 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

4

 

 

 

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIENCY

(Unaudited)

 

Three and Six Months Ended March 31, 2023 and 2022

 

                      
               Accumulated  Total
   Common Stock  Additional  Stock  Accumulated  Comprehensive  Stockholders’
   Shares  Amount  Paid-in  Receivable  Deficit  Income  Deficit
                      
Balance, September 30, 2022   374,305,480    3,748    63,527,513    (795,000)   (67,070,016)   290,563    (4,043,192)
Shares issued in connection with the sale of common stock   —      —      —      —      —      —      —   
Stock-based compensation expense   —      —      —      —      —      —      —   
Foreign currency translation adjustment   —      —      —      —      —      (74,455)   (74,455)
Net loss   —      —      —      —      (176,458)   —      (176,458)
Balance, December 31, 2022   374,305,480    3,748    63,527,513    (795,000)   (67,246,474)   216,108    (4,294,105)
Shares issued in connection with the sale of common stock   —      —      —      —      —      —      —   
Settlement of Notes   237,130    3    65,208    —      —      —      65,211 
Stock-based compensation expense   —      —      —      —      —      —      —   
Foreign currency translation adjustment   —      —      —      —      —      16,566    16,566 
Net loss   —      —      —      —      (199,901)   —      (199,901)
Balance, March 31, 2023   374,542,610    3,751    63,592,721    (795,000)   (67,446,375)  $232,674   $(4,412,229)

 

 

 

5

 

 

               Accumulated  Total
   Common Stock  Additional  Stock  Accumulated  Comprehensive  Stockholders’
   Shares  Amount  Paid-in  Receivable  Deficit  Income  Deficit
                      
Balance, September 30, 2021   343,237,369    3,437    49,922,922    (720,000)   (46,050,640)   107,902    3,263,621 
Shares issued in connection with the sale of common stock   1,200,000    12    121,909    (75,000)   —      —      46,921 
Stock-based compensation expense   18,386,364    184    12,382,316    —      —      —      12,382,500 
Foreign currency translation adjustment   —      —      —      —      —      (9,246)   (9,246)
Net loss   —      —      —      —      (12,850,758)   —      (12,850,758)
Balance, December 31, 2021   362,823,733    3,633    62,427,147    (795,000)   (58,901,398)   98,656    2,833,038 
Shares issued in connection with the sale of common stock   —      —      —      —      —      —      —   
Beneficial conversion discount on convertible notes payable        —      —      —      —      —      —   
Stock-based compensation expense   —      —      —      —      —      —      —   
Foreign currency translation adjustment   —      —      —      —      —      (47,456)   (47,456)
Net loss   —      —      —      —      (440,305)   —      (440,305)
Balance, March 31, 2022   362,823,733    3,633    62,427,147    (795,000)   (59,341,703)  $51,200   $2,345,277 

 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

6

 

 

  

GRAPHENE & SOLAR TECHNOLOGIES LIMITED 

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS 

For the Six-Month Period Ended March 31, 2023 and 2022 

(Unaudited)

 

       
   2023  2022
Cash flows from operating activities          
Net Income (loss)  $(376,359)  $(13,291,063)
Adjustments to reconcile net income/(loss) to net cash from operating activities:          
Stock-based compensation   —      12,382,500 
Depreciation expense   169    521 
Amortization of intangibles   —      490,064 
Amortization of discount   —      13,943 
Loss on Settlement of Debt   40,441    —   
Change in operating assets and liabilities:          
Accounts payable   88,344    142,409 
Accrued interest payable   10,134    11,485 
Accrued liabilities          
Other Receivables   (1,921)   (2,094)
Pre-Payments   —      —   
Due to related parties   195,304    203,128 
Net cash used in operating activities   (43,888)   (49,107)
           
Cash flows from investing activities          
 Cash paid for purchase of fixed assets   —      —   
Net cash used in investing activities   —      —   
           
Cash flows from financing activities          
Proceeds from issuance of common stock   —      46,921 
Due to Affiliates   41,892    —   
Issuance of short term note payable, net of OID   —      —   
Net cash from financing activities   41,892    46,921 
Effect of currency translations to cash flow   9,488    (2,654)
Net change in cash and cash equivalents   7,492    468 
Beginning of period   2,857    3,728 
End of period  $10,349   $4,196 

Supplemental cash flow information  Quarter ended March 31,
   2023  2022
Interest paid  $—     $—   
Taxes  $—     $—   
Noncash investing and financing activities:          
Settlement of Debt for Common Stock   24,770    —   

 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

7

 

    

GRAPHENE & SOLAR TECHNOLOGIES Limited

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

NOTE 1 – BASIS OF PRESENTATION

 

These consolidated financial statements of Graphene &Solar Technologies Limited (GSTX or the Company) have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). In the opinion of management, these financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. Certain information, accounting policies and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to Securities and Exchange Commission (SEC) rules and regulations. These financial statements should be read along with Graphene & Solar Technologies’ audited financial statements as of September 30, 2022.

 

Going Concern – The Company has incurred cumulative net losses since inception of $67,446,376 at March 31, 2023. Accordingly, it requires capital to fund working capital deficits and for future operating activities to take place. The Company’s ability to raise new funds through the future issuances of debt or common stock is unknown. The obtainment of additional financing, the successful development of a plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability of the Company to continue its operations is dependent on management’s plans, which include the raising of capital through debt and/or equity markets, with some additional funding from other traditional financing sources, including term notes, until such time that funds provided by operations are sufficient to fund working capital requirements. The Company may need to incur additional liabilities with certain related parties to sustain the Company’s existence. There can be no assurance that the Company will be able to raise any additional capital and therefore raise doubt about the Company’s ability to continue as a going concern.

 

Future issuances of the Company’s equity or debt securities will be required for the Company to finance operations and continue as a going concern. The financial statements do not include any adjustments that may result from the outcome of these uncertainties.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

 

Principles of Consolidation and Basis of Presentation — The consolidated financial statements include the accounts of Graphene & Solar Technologies Limited and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). A summary of the significant accounting policies applied in the preparation of the accompanying financial statements can be found in the Company’s Annual Report in form 10-K for the year ended September 30, 2022.

 

Use of Estimates - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Significant estimates include but are not limited to the estimated useful lives of equipment for purposes of depreciation and the valuation of common shares issued for services, equipment and the liquidation of liabilities.

 

Cash and Cash Equivalents-Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments. As of March 31, 2023 and 2022, the Company had $10,349 and $4,196 in cash, respectively, and no cash equivalents.

 

Derivative Financial Instruments – The Company accounts for freestanding contracts that are settled in a company’s own stock, including common stock warrants, to be designated as an equity instrument or generally as a liability. A contract so designated is carried at fair value on a company’s balance sheet, with any changes in fair value recorded as a gain or loss in a company’s results of operations.

 

The Company records all derivatives on the balance sheet at fair value, adjusted at the end of each reporting period to reflect any material changes in fair value, with any such changes classified as changes in derivatives valuation in the statement of operations. The calculation of the fair value of derivatives utilizes highly subjective and theoretical assumptions that can materially affect fair values from period to period. The recognition of these derivative amounts does not have any impact on cash flows.

8

 

 

At the date of the conversion of any convertible debt, the pro rata fair value of the related embedded derivative liability is transferred to additional paid-in capital.

 

There was no derivative activity in fiscal quarter ending March 31, 2023. Therefore, no derivative liabilities were recorded during the quarter ended March 31, 2023.

 

Stock-Based Compensation -ASC 718, “Compensation - Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees and non-employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values on the grant date. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

 

During the quarter ended March 31, 2023, the Company issued 237,130 shares of the Company’s common stock.

 

Total stock-based compensation expense was $0 for the six-months ended March 31, 2023.

 

Foreign Currency Translations – The functional currency of the Company’s foreign subsidiary is primarily the respective local currency. Assets and liabilities of the Company’s foreign subsidiary are translated into U.S. Dollars at the year-end exchange rate, and revenues and expenses are translated at average monthly exchange rates. Translation gains and losses are recorded as a component of accumulated other comprehensive income (loss) within stockholders’ equity. All other foreign currency transaction gains and losses are included in other (income) expense, net.

 

Earnings Per Share - Basic earnings per share have been calculated based upon the weighted-average number of common shares outstanding. Diluted earnings per share were not calculated as such potential shares would be anti-dilutive.

 

Reclassifications - Certain amounts previously presented for prior periods have been reclassified to conform to the current presentation. The reclassifications had no effect on net loss, working capital or equity previously reported. 

 

NOTE 3 – NOTES PAYABLE

 

The Company’s indebtedness as of March 31, 2023 and September 30, 2022 were as follows:

       
Description  March 31,
2023		  September 30, 2022
       
Convertible notes  $100,747   $100,747 
Notes Payable  $60,000   $76,255 
Notes Payable – Related Parties  $41,892   $—   

 

Notes Payable and Other Loans

 

During 2015 and 2016, the Company executed promissory notes payable with six individuals with an aggregate principal balance of $60,000. The notes were due on demand and included interest at 10%. As of March 31, 2023 and September 30, 2022, the total promissory notes payable balance was $105,701 and $99,701 including accrued interest of $45,701 and $39,701, respectively. On January 15, 2019, the holder of a note with a principal balance of $10,000 made demand for payment. To date, the note has not been paid.

 

During the year ended September 30, 2020 a Company Advisor, loaned the Company $5,781. The loan is a demand note at zero interest.

9

 

 

Convertible Notes Payable

 

As of March 31, 2023 and September 30, 2022, noteholders representing $70,747 in outstanding principal had not requested the exchange of shares of common stock. As of March 31, 2023 and September 30, 2022, the exchange obligation payable was $ 174,188.98 and $168,897.47 including accrued interest of $103,442 and $98,150, respectively. As of March 31, 2023 and September 30, 2022, the exchange obligation was for 52,625 shares and 51,026 shares of common stock, respectively.

 

On February 1, 2016, the Company issued convertible secured note payable of $30,000 to an individual. The note was due on January 31, 2017 and included interest at 10%. The note was convertible at discretion of the holder into common shares of the Company at the rate of $0.50 per shares. The Company has not extended the maturity date and the note is in default. As of March 31, 2023 and September 30, 2022, the total convertible note payable balance was $51,493 and $49,997, including accrued interest of $21,493 and $19,997 respectively. As of March 31, 2023 and September 30, 2022, the exchange obligation was for 102,986 shares and 99,994 shares of common stock, respectively.

 

NOTE 4 – RELATED PARTY

 

CSA Liang Pty Ltd, a management company controlled by the Company’s Chief Executive Officer, and a Company Director, provides management services to the Company for which the Company is charged $20,833 monthly. During the three months ended March 31, 2023, the Company incurred charges to operations of $62,499 with respect to this arrangement.

 

On October 1, 2022, Mr. Andrew Liang signed a formal agreement with the Company to perform services of a Chief Executive Officer. Mr. Liang shall be issued 30,000,000 shares at the start of the contract. This is calculated as 10,000,000 shares for every year of this consulting agreement. Should the contract be terminated early, then the company has the right to purchase back a pro-rata portion of the 30,000,000 shares based on time served out of the 36-month contract. As of this filing date, the 30,000,000 shares have been approved but remain unissued.

 

On December 5, 2022, the Company entered into a Promissory Loan Note with Mr. Andrew Liang, in the amount of US$20,000, with a maturity date of December 5, 2023. The loan will accrue interest at the rate of 10% per annum.

 

On February 28, 2023, the Company entered into a Promissory Loan Note with MI Labs Pty Ltd, in the amount of US$50,000 (of which $21,892 was received by the company as of March 31, 2023) with a maturity date of February 28, 2024. The loan will accrue interest at the rate 10% per annum.

 

Mr. Thomas Chang was granted a maximum of 1,000,000 shares per annum subject to performance in fiscal years 2021/2022, 2022/2023 and 2023/2024 to a total of 3,000,000 shares. 1,000,000 shares were issued during the 2021/2022 fiscal year. As of this filing date, the remaining 2,000,000 shares have been approved but remain unissued.

 

During the quarters ended March 31, 2023 and 2022, stock-based compensation expense relating to directors, officers, affiliates and related parties was $0 (no shares) and $2,485,000 (3,500,000 shares), respectively.

 

NOTE 5 – STOCKHOLDERS’ EQUITY

 

237,130 new common shares were issued during the six- month period ending March 31, 2023 to settle accounts payable debt. The share prices at time of issuance was $0.2750, resulting in a loss on settlement of $40,441. 

 

The Company has a total of 5,778,366 shares that remain approved, reserved and outstanding and not yet issued by the Transfer Agent at March 31, 2023

10

 

 

NOTE 6 – COMMITMENTS & CONTINGENCIES

 

Contingencies

 

From time to time, we may be involved in routine legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. The ultimate amount of liability, if any, for any claims of any type (either alone or in the aggregate) may materially and adversely affect our financial condition, results of operations and liquidity. In addition, the ultimate outcome of any litigation is uncertain. Any outcome, whether favorable or unfavorable, may materially and adversely affect us due to legal costs and expenses, diversion of management attention and other factors. We expense legal costs in the period incurred. We cannot assure you that additional contingencies of a legal nature or contingencies having legal aspects will not be asserted against us in the future, and these matters could relate to prior, current or future transactions or events. As of March 31, 2023, there were no pending or threatened litigation against the Company.

 

NOTE 7 – INTANGIBLE ASSETS/PATENTS

 

We capitalize external costs, such as filing fees and associated attorney fees, incurred to obtain issued patents and patent license rights. We expense costs associated with maintaining and defending patents subsequent to their issuance in the period incurred. We amortize capitalized patent costs for internally generated patents on a straight-line basis for 7 years, which represents the estimated useful lives of the patents. The seven-year estimated useful life for internally generated patents is based on our assessment of such factors as: the integrated nature of the portfolios being licensed, the overall makeup of the portfolio over time, and the length of license agreements for such patents. The estimated useful lives of acquired patents and patent rights, however, have been and will continue to be based on a separate analysis related to each acquisition and may differ from the estimated useful lives of internally generated patents. The average estimated useful life of acquired patents is 6.7 years. We assess the potential impairment to all capitalized net patent costs when events or changes in circumstances indicate that the carrying amount of our patent portfolio may not be recoverable.

       
   March 30, 2023  March 30, 2022
Patents   1    6,879,745 
Accumulated amortization   —      (592,385)
Total patent costs, net   1    6,287,360 

 

NOTE 8 – SUBSEQUENT EVENTS

 

On April 1, 2023, Mr. Jason May was appointed Chief Executive Officer by the Board of Directors. Mr. Andrew Liang has stepped down from the CEO role but remains a Director on the Board. Mr. May was granted 2,000,000 shares per the terms of the agreement. As of this filing date, the 2,000,000 shares have been approved but remain unissued.

 

On April 1, 2023, Mr. Charles Wantrup was appointed Corporate Secretary by the Board of Directors.

 

On April 1, 2023, Mr. Arnold Sock signed a services agreement with the Company and was issued 5,000,000 shares per the terms of the agreement.

 

On April 12, 2023, Mr. Raymond Purdon signed a consulting agreement with the Company and was issued 5,000,000 shares per the terms of the agreement.

 

On April 27, 2023, Brookside Communications signed a consulting agreement with the Company and was issued 250,000 shares per the terms of the agreement.

 

The Company has evaluated events occurring subsequent to March 31, 2023 through to the date these financial statements were issued and has identified no additional events requiring disclosure.

 

11

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND PLAN OF OPERATION

 

The following discussion of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes, and other financial information included in this Form 10-Q.

 

Our Management’s Discussion and Analysis contains not only statements that are historical facts, but also statements that are forward-looking. Forward-looking statements are, by their very nature, uncertain and risky. Although the forward-looking statements in this Quarterly Report reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by them. Consequently, and because forward-looking statements are inherently subject to risks and uncertainties, the actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. You are urged to carefully review and consider the various disclosures made by us in this report as we attempt to advise interested parties of the risks and factors that may affect our business, financial condition, and results of operations and prospects.

 

FORWARD LOOKING STATEMENTS

 

The information contained in this Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve risks and uncertainties, including among other things, statements regarding our capital needs, business strategy and expectations. Any statement which does not contain a historical fact may be deemed to be a forward-looking statement. In some cases, you can identify forward-looking statements by terminology such as “may”, “will”, “should”, “expect”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict”, “potential” or “continue”, the negative of such terms or other comparable terminology. In evaluating forward looking statements, you should consider various factors outlined in our Form 10-K report for the year ended September 30, 2022, filed with the U.S. Securities Exchange Commission (“SEC”) and, from time to time, in other reports we file with the SEC. These factors may cause our actual results to differ materially from any forward-looking statement. We disclaim any obligation to publicly update these statements or disclose any difference between our actual results and those reflected in these statements.

 

Overview

 

We are primarily focused on providing the materials and technologies for a greener future. GSTX has a portfolio of projects in the cleantech are with:

 

  • Patented and novel technologies.

 

  • Proven products with exclusive geographical distribution rights.

 

  • Ground-breaking new innovations.

 

  • Mineral resources that critical to the high-tech supply chain.

 

These investments focus on global opportunities, multi-billion-dollar industries, with a significant positive environmental impact. GSTX is focused on projects with exceptionally strong business opportunities, taking advantage of the environmental and supply chain challenges the world faces at present. GSTX is currently focused on supplying advanced materials to existing manufacturers and water harvesting products to market.

 

Advanced Materials

A portfolio of proprietary technologies for upstream manufacturing material supply into high tech markets including solar, semiconductor, defense.

 

  • The Dragonfly range of transparent conductive thin films.

 

  • High purity quartz sand production.

 

  • High purity graphite production.

 

12

 

Water Technologies

A portfolio of products and technologies for providing clean drinkable water for consumers and industry.

 

  • Ambient water harvesting equipment.

 

  • The company is also exploring opportunities in water remediation, oils spill clean-up.

 

The Company is also exploring acquisition opportunities for Critical Resources Assets (Minerals with identified supply chain risk), zero emission fossil fuel replacement, green hydrogen, and ammonia production.

 

Operational Overview.

 

US Thin Films

 

US Thin-Film Corporation, a 100% owned subsidiary of GSTX holds a Patent Portfolio (IP) relating to the novel leading-edge production of conductive transparent thin films. The thin films are based on a conductive nanoparticle technology, an innovative conductive coating that self-assembles into a random mesh-like network pattern when coated, providing excellent electrical conductivity, high transparency, and flexibility. The Technology was founded and developed in Israel and has built up significant R&D profile for over 15 years with more than USD $90 Million invested. The technology has won several international touchscreen technology awards.

 

Applications of the proprietary thin film in existing electronics applications outperforms current materials. Key applications include: Electromagnetic Interference (EMI) Shielding, Flexible Transparent Antennas (4G/5G communications), Transparent Heaters (windows, goggles, etc), Touch Displays (monitors, phones, tablets), Photovoltaic, OLED Lighting, Flexible Displays, Sensors, and numerous other electronic applications

 

The US Thin-Film technology is superior to traditional/existing technology with multiple times the electrical conductivity of conventional ITO based transparent conductive films with a simple manufacturing method protected by the company’s patent portfolio.

 

The company is presently in discussions with several contract manufacturing groups to produce initial samples of its thin film technology, branded Dragonfly film, for product qualification and pre-sales activity purposes.

 

Water Harvesting

 

Water scarcity is at the center of the world’s most significant challenges. The United Nations estimates approximately 30% of the world’s population will face severe water shortages by 2025. Many people do not realise that the atmosphere, the air we breathe, contains a significant amount of water. Humidity is water in the air. Air can hold 1-2 ounces of water per cubic yard. At any one instant, the Earth’s atmosphere contains 37.5 trillion gallons of water vapor – enough to cover the entire surface of the planet with 1.5 inches of rain if condensed.

 

In parallel, massive population growth and urbanisation has led to an unprecedented demand for fresh water. Investment in infrastructure has been woefully inadequate, resulting in severe and critical water stress globally.

 

There are an estimated 13 trillion litres (3.4 trillion gal) of water floating in the atmosphere at any one time. There is 6 times as much fresh water in the air as in all rivers and lakes in the world.

 

13

 

The Company is continuing commercialization of a unique water harvesting technology utilizing modular, self-contained units that can be solar or grid powered, and deployed in urban and rural environments. The water harvesters will extract moisture from the ambient air and lect as 100% pure fresh water. Each domestic water harvester will be capable of generating 30-50 liters (8-13 gal) of pure fresh water per day for personal use, with commercial models lecting up to 50,000 liters (13,000 gal) per day. The 100% pure H20 extracted from the atmosphere is also suitable for industrial use in green hydrogen production and pharmaceutical, semiconductor processing plants.

 

A 100% operational subsidiary has been established for the water harvesting products. It will trade as Adaquo, which is a Latin verb meaning to supply water. The company has engaged the services of two industry veterans (20+ years experience) to assist with commercialization of the technology.

 

Whilst still undertaking in house development of the company’s proprietary solid-state technology, the company is also exploring opportunities to license and distribute existing products that have been market proven on an exclusive geographical basis.

 

Quartz Material.

 

The company has significant technical expertise and experience in the high purity quartz sector. Initially, the company focused upon acquiring resources and developing high purity silica (99.9% purity) into commercial grade high purity quartz sand (HPQS 99.997% purity). HPQS is essential for the production of semiconductors and photovoltaic solar panels.

 

Although the enterprise was successful in identifying substantial resources and valuable customers in Japan, China, South Korea, Taiwan and South-East Asia, the company was unable to secure funding to scale to meet demand for HPQS product, largely due to complications with the onset of Covid-19 in March 2020. The COVID Pandemic saw significant disruption to the global solar and semiconductor manufacturing sector. This had significant flow on effects to HPQS market. It is anticipated that by mid-2023 the sector will be substantially recovered to pre-covid levels of production and associated demand for raw materials. At present manufacturing levels of solar cells are showing strong growth and a swift recovery.

 

The company is presently re-engaging with past acquisition opportunities and customers in the HPQ sector. At present there is a significant production shortfall for the material and prices/volumes are showing strong growth. The company is continuing to pursue the development of an Australian based production facility.

 

Graphene Material.

 

Graphene, a new material, was discovered in 2004 by two UK based Russian university professors who were awarded the Nobel Prize in 2010 for their discovery. Graphene is a 2D material, (one atom thickness) made from graphite/carbon atoms, and whilst still largely unknown to the world is rapidly becoming a new industrial revolution in its own right with more than 8,800 patent applications for graphene and graphene enabled product applications having been filed recently. We have taken an early-stage leading-edge position in this evolving new technological field of graphene enabling and enhancement, specifically to focus upon development of graphene enabled photovoltaic solar panels.

 

Graphene is the world’s thinnest and strongest material ever, with remarkable electrical, thermal, and optical properties being the most conductive material ever scientifically measured. A sheet of graphene material is only one single atom in thickness and is referred to as a 2D nano-material having almost no measurable depth, only length and width. Graphene is also highly transparent and can be easily flexed and stretched 25% of its size without breaking. However, it is also 200 times stronger than steel and harder than a diamond. Graphene material is completely impermeable, even a helium atom (the smallest) cannot pass through graphene. The advent of graphene and the introduction of the extraordinary benefits from combining graphene with existing materials and products.

 

Our main focus remains dedicated to our original premise of producing low cost, high grade, high purity graphene for industrial sales to existing materials groups.

14

 

 

Results of Operations

 

For the fiscal quarters ended March 31, 2023 and 2022, we generated no revenues, and thus no cost of sales or gross profits.

 

For the fiscal quarters ended March 31, 2023 and 2022, we incurred $165,100 and $442,064 respectively in operating expenses.

 

For the fiscal quarter ended March 31, 2023 we recorded other expenses of $5,022, while in the fiscal quarter ended March 31, 2022, we incurred expenses of $4,835; both items are represented by accrued interest on debt.

 

For the fiscal quarter ended March 31, 2023, we recorded other income of $10,662, while in the fiscal quarter ended March 31, 2022, we recorded other income of $6,594.

 

For the fiscal quarter ended March 31, 2023, $40,441 was recognized as loss on extinguishment of debt, while in the fiscal quarter ended March 31, 2022 we recorded $0.

 

For the six months ended March 31, 2023, we reported net loss before taxes of $376,359 while in the six months ended March 31, 2022, we reported a net loss before taxes of $13,291,063. Since there were no tax obligations in either year, net income / loss in each year was the same as that reported before taxes.

 

For the periods ended September 30, 2022 and March 31, 2023, our cash positions were $2,857 and $10,349 respectively.

 

As of March 31, 2023, we had total current liabilities of $4,440,258 while as of September 30, 2022, we had total current liabilities of $4,061,574 an increase of about 9%. Accrued interest payable increased from $161,602 to $171,736 all attributable to accruals on the loans and the convertible notes payable.

 

Liquidity and Capital Resources

 

As of March 31, 2023, we had $21,894 in total current assets and $4,440,259 in total current liabilities. Accordingly, we had a working capital deficit of $4,418,364.

 

Cash used in operating activities was $44,559 for the quarter ended March 31, 2023, as compared to $49,107 cash used in operating activities for the quarter ended March 31, 2022.

 

Net cash provided by financing activities was $41,892 for the quarter ended March 31, 2023, as compared to $46,921 for the quarter ended March 31, 2022. 

15

 

 

Off-Balance Sheet Arrangements

 

There are no off-balance sheet arrangements.

 

Critical Accounting Policies and Estimates

 

For a discussion of our accounting policies and related items, please see the Notes to the Financial Statements, included in Item 1.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK.

 

Not applicable.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures

 

An evaluation was carried out under the supervision and with the participation of our management, including our Principal Executive and Interim Financial Officer, of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report on Form 10-Q. Disclosure controls and procedures are procedures designed with the objective of ensuring that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, such as this Form 10-Q, is recorded, processed, summarized and reported, within the time period specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and is communicated to our management, including our Principal Executive [and Financial Officer], or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on that evaluation, our management concluded that, as of December 31, 2020, our disclosure controls and procedures were not effective.

 

Management conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2020, based on the framework established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013 (“COSO”).

 

As of period covered by this Quarterly Report on Form 10-Q, we have concluded that our internal control over financial reporting was ineffective. The Company’s assessment identified certain material weaknesses which are set forth below:

 

Functional Controls and Segregation of Duties

 

Because of the Company’s limited resources, there are limited controls over information processing.

 

There is an inadequate segregation of duties consistent with control objectives. Our Company’s management is composed of a small number of individuals resulting in a situation where limitations on segregation of duties exist. In order to remedy this situation, we would need to hire additional staff to provide greater segregation of duties. Currently, it is not feasible to hire additional staff to obtain optimal segregation of duties. Management will reassess this matter in the following year to determine whether improvement in segregation of duty is feasible.

 

Accordingly, as the result of identifying the above material weakness we have concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the Company’s internal controls.

 

 

16

 

 

Management’s Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting and for the assessment of the effectiveness of internal control over financial reporting. As defined by the Securities and Exchange Commission, internal control over financial reporting is a process designed by, or under the supervision of our Principal Executive and Financial Officer and implemented by our Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements in accordance with U.S. generally accepted accounting principles.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Roger May, our Principal Executive Officer, evaluated the effectiveness of our internal control over financial reporting as of December 31, 2020 based on criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission, or the COSO Framework (2013). Management’s assessment included an evaluation of the design of our internal control over financial reporting and testing of the operational effectiveness of those controls.

 

Changes in Internal Control Over Financial Reporting

 

There was no change in our internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

Management has addressed the underlying causes for our weaknesses in internal control since early FY 2020. Our efforts to raise both debt and equity capital soon will allow us to undertake additional engagement of external independent consultants to assist with the processing of data and drafting financial reports on a timely basis in future reporting periods.

 

 

17

 

 

 

PART II

 

ITEM 1. LEGAL PROCEEDINGS

 

None.

 

ITEM 1A. RISK FACTORS

 

Our business is subject to numerous risks and uncertainties including but not limited to those discussed in “Risk Factors” in our annual report on Form 10-K.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Please see Note 5 to our Financial Statements.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

None.

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS

 

Exhibits

 

31.1 Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
31.2 Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
32.1 Certification pursuant to Section 906 of the Sarbanes-Oxley Act.
   
32.2 Certification pursuant to Section 906 of the Sarbanes-Oxley Act.

 

18

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  GRAPHENE & SOLAR TECHNOLOGIES LIMITED
     
Date: August 4, 2023 By: /s/ Jason May
    Chief Executive Officer and Director

 

 

19

  

 

 

 

 

 

 

EXHIBIT 31.1

 

CERTIFICATIONS

 

I, Jason May, certify that;

 

1. I have reviewed this quarterly report on Form 10-Q of Graphene & Solar Technologies Limited;
   
2. Based on my knowledge, this report, does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by the report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 4, 2023 By: /s/ Jason May
    Jason May
    Chief Executive Officer and Director

 

 

 

 

 

 

EXHIBIT 31.2

 

CERTIFICATIONS

 

I, David AB Halstead, certify that;

 

1. I have reviewed this quarterly report on Form 10-Q of Graphene & Solar Technologies Limited;
   
2. Based on my knowledge, this report, does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by the report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 4, 2023 By: /s/ David AB Halstead
    David AB Halstead
Chief Financial Officer and Director

  

 

 

 

  

EXHIBIT 32.1

 

In connection with the Quarterly Report of Graphene & Solar Technologies Limited (the “Company”) on Form 10-Q for the period ending March 31, 2023 as filed with the Securities and Exchange Commission (the “Report”), Jason May, the Chief Executive Officer and Director of the Company, certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
     
  (2) The information contained in the Report fairly presents, in all material respects the financial condition and results of operations of the Company.

 

Date: August 4, 2023 By: /s/ Jason May
    Jason May
    Chief Executive Officer and Director

 

 

 

 

   

EXHIBIT 32.2

 

In connection with the Quarterly Report of Graphene & Solar Technologies Limited (the “Company”) on Form 10-Q for the period ending March 31, 2023 as filed with the Securities and Exchange Commission (the “Report”), David A.B. Halstead, the Chief Financial Officer and Director of the Company, certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
     
  (2) The information contained in the Report fairly presents, in all material respects the financial condition and results of operations of the Company.

 

Date: August 4, 2023 By: /s/ David Halstead
    David Halstead,
    Chief Financial Officer and Director

 

 

 

v3.23.2
Cover - shares
 6 Months Ended
Mar. 31, 2023
Aug. 04, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2023  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --09-30  
Entity File Number 333-174194  
Entity Registrant Name GRAPHENE & SOLAR TECHNOLOGIES LTD  
Entity Central Index Key 0001497649  
Entity Tax Identification Number 27-2888719  
Entity Incorporation, State or Country Code CO  
Entity Address, Address Line One 23 Corporate Plaza Drive  
Entity Address, Address Line Two Suite 150  
Entity Address, City or Town Newport Beach  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 92660  
City Area Code (949)  
Local Phone Number 478-8387  
Entity Current Reporting Status Yes  
Entity Interactive Data Current No  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   384,792,610
v3.23.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2023
Sep. 30, 2022
Current Assets:    
Cash $ 10,349 $ 2,857
Prepaid expenses 11,545 11,183
Total Current Assets 21,894 14,040
Other Assets:    
Furniture and equipment, net of depreciation $79,916 1,144 1,273
Intellectual property – at cost, net 1
Other intangible assets – at cost 975 975
Other receivable 4,015 2,094
Total Assets 28,029 18,382
Current Liabilities:    
Accounts payable and other payable 2,489,799 2,380,565
Accrued interest payable 171,736 161,602
Due to related parties 1,576,084 1,342,405
Notes payable – in default 60,000 76,255
Convertible notes payable, net of discount $0 and $100,747 in default 100,747 100,747
Notes payable – Related Party 41,892
Total Current Liabilities 4,440,258 4,061,574
Total Liabilities 4,440,258 4,061,574
Preferred stock: 10,000,000 shares authorized; $0.00001 par value; no shares issued and outstanding
Common stock: 500,000,000 shares authorized; $0.00001 par value; 374,542,610 and 374,305,480 shares issued and outstanding 3,751 3,748
Additional paid-in capital 63,592,721 63,527,513
Accumulated deficit (67,446,375) (67,070,016)
Stock Receivable (795,000) (795,000)
Accumulated other comprehensive income 232,674 290,563
Total Stockholders’ Deficit (4,412,229) (4,043,192)
Total Liabilities and Stockholders’ Deficit $ 28,029 $ 18,382
v3.23.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
Mar. 31, 2023
Sep. 30, 2022
Statement of Financial Position [Abstract]    
Furniture and equipment, net of depreciation $ 79,916  
Debt Discount $ 0 $ 100,747
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, par value $ 0.00001 $ 0.00001
Preferred stock, issued 0 0
Preferred stock, outstanding 0 0
Common stock, authorized 500,000,000 500,000,000
Common stock, par value $ 0.00001 $ 0.00001
Common stock, issued 374,542,610 374,305,480
Common stock, outstanding 374,542,610 374,305,480
v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME - USD ($)
 3 Months Ended 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]        
Revenues
Operating expenses        
Professional Services 153,253 172,282 288,107 12,726,455
General and administrative 11,847 269,782 54,638 550,456
Total operating expenses 165,100 442,064 342,745 13,276,911
Loss from operations (165,431) (442,064) (342,745) (13,276,911)
Other income (expense)        
Other income 10,662 6,594 16,962 11,276
Interest expense (5,022) (4,835) (10,135) (25,428)
Loss on extinguishment of debt (40,441) (40,441)
Total other income (expense) (34,801) 1,759 (33,614) (14,152)
Net Income (Loss) (199,901) (440,305) (376,359) (13,291,063)
Other Comprehensive Income 16,566 (47,456) (57,889) (56,702)
Net Comprehensive Loss $ (183,335) $ (487,761) $ (434,248) $ (13,347,765)
Income (Loss) per share:        
Basic and diluted $ (0.00) $ (0.00) $ (0.00) $ (0.04)
Weighted average shares outstanding 374,310,750 362,823,733 374,308,086 360,019,487
v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS DEFICIENCY - USD ($)
 3 Months Ended 6 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Mar. 31, 2022
Dec. 31, 2021
Mar. 31, 2023
Mar. 31, 2022
Balance, December 31, 2021 $ (4,294,105) $ (4,043,192) $ 2,833,038 $ 3,263,621 $ (4,043,192) $ 3,263,621
Shares issued in connection with the sale of common stock 46,921    
Stock-based compensation expense 12,382,500    
Foreign currency translation adjustment 16,566 (74,455) (47,456) (9,246)    
Net loss (199,901) (176,458) (440,305) (12,850,758) (376,359) (13,291,063)
Settlement of Notes 65,211          
Balance, March 31, 2022 (4,412,229) (4,294,105) 2,345,277 2,833,038 (4,412,229) 2,345,277
Beneficial conversion discount on convertible notes payable          
Common Stock [Member]            
Balance, December 31, 2021 3,748 $ 3,748 $ 3,633 $ 3,437 $ 3,748 $ 3,437
Shares, Outstanding, Beginning Balance   374,305,480 362,823,733 343,237,369 374,305,480 343,237,369
Shares issued in connection with the sale of common stock $ 12    
Stock-based compensation expense 184    
Foreign currency translation adjustment    
Net loss    
Settlement of Notes $ 3          
Settlement of notes 237,130          
Balance, March 31, 2022 $ 3,751 3,748 3,633 $ 3,633 $ 3,751 $ 3,633
Shares, Outstanding, Ending Balance 374,542,610     362,823,733 374,542,610  
Shares issued in connection with the sale of common stock       1,200,000    
Stock-based compensation expense       18,386,364    
Beneficial conversion discount on convertible notes payable          
Additional Paid-in Capital [Member]            
Balance, December 31, 2021 $ 63,527,513 63,527,513 62,427,147 $ 49,922,922 $ 63,527,513 49,922,922
Shares, Outstanding, Beginning Balance 374,305,480          
Shares issued in connection with the sale of common stock 121,909    
Stock-based compensation expense 12,382,316    
Foreign currency translation adjustment    
Net loss    
Settlement of Notes 65,208          
Balance, March 31, 2022 63,592,721 $ 63,527,513 62,427,147 62,427,147 63,592,721 62,427,147
Shares, Outstanding, Ending Balance   374,305,480        
Beneficial conversion discount on convertible notes payable          
Stock Receivable [Member]            
Balance, December 31, 2021 (795,000) $ (795,000) (795,000) (720,000) (795,000) (720,000)
Shares issued in connection with the sale of common stock (75,000)    
Stock-based compensation expense    
Foreign currency translation adjustment    
Net loss    
Settlement of Notes          
Balance, March 31, 2022 (795,000) (795,000) (795,000) (795,000) (795,000) (795,000)
Beneficial conversion discount on convertible notes payable          
Retained Earnings [Member]            
Balance, December 31, 2021 (67,246,474) (67,070,016) (58,901,398) (46,050,640) (67,070,016) (46,050,640)
Shares issued in connection with the sale of common stock    
Stock-based compensation expense    
Foreign currency translation adjustment    
Net loss (199,901) (176,458) (440,305) (12,850,758)    
Settlement of Notes          
Balance, March 31, 2022 (67,446,375) (67,246,474) (59,341,703) (58,901,398) (67,446,375) (59,341,703)
Beneficial conversion discount on convertible notes payable          
AOCI Attributable to Parent [Member]            
Balance, December 31, 2021 216,108 290,563 98,656 107,902 290,563 107,902
Shares issued in connection with the sale of common stock    
Stock-based compensation expense    
Foreign currency translation adjustment 16,566 (74,455) (47,456) (9,246)    
Net loss    
Settlement of Notes          
Balance, March 31, 2022 $ 232,674 $ 216,108 51,200 $ 98,656 $ 232,674 $ 51,200
Beneficial conversion discount on convertible notes payable          
v3.23.2
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities    
Net Income (loss) $ (376,359) $ (13,291,063)
Adjustments to reconcile net income/(loss) to net cash from operating activities:    
Stock-based compensation 12,382,500
Depreciation expense 169 521
Amortization of intangibles 490,064
Amortization of discount 13,943
Loss on Settlement of Debt 40,441
Change in operating assets and liabilities:    
Accounts payable 88,344 142,409
Accrued interest payable 10,134 11,485
Other Receivables (1,921) (2,094)
Pre-Payments
Due to related parties 195,304 203,128
Net cash used in operating activities (43,888) (49,107)
Cash flows from investing activities    
 Cash paid for purchase of fixed assets
Net cash used in investing activities
Cash flows from financing activities    
Proceeds from issuance of common stock 46,921
Due to Affiliates 41,892
Issuance of short term note payable, net of OID
Net cash from financing activities 41,892 46,921
Effect of currency translations to cash flow 9,488 (2,654)
Net change in cash and cash equivalents 7,492 468
Beginning of period 2,857 3,728
End of period 10,349 4,196
Supplemental cash flow information    
Interest paid
Taxes
Noncash investing and financing activities:    
Settlement of Debt for Common Stock $ 24,770
v3.23.2
BASIS OF PRESENTATION
 6 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
BASIS OF PRESENTATION

NOTE 1 – BASIS OF PRESENTATION

 

These consolidated financial statements of Graphene &Solar Technologies Limited (GSTX or the Company) have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). In the opinion of management, these financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. Certain information, accounting policies and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to Securities and Exchange Commission (SEC) rules and regulations. These financial statements should be read along with Graphene & Solar Technologies’ audited financial statements as of September 30, 2022.

 

Going Concern – The Company has incurred cumulative net losses since inception of $67,446,376 at March 31, 2023. Accordingly, it requires capital to fund working capital deficits and for future operating activities to take place. The Company’s ability to raise new funds through the future issuances of debt or common stock is unknown. The obtainment of additional financing, the successful development of a plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability of the Company to continue its operations is dependent on management’s plans, which include the raising of capital through debt and/or equity markets, with some additional funding from other traditional financing sources, including term notes, until such time that funds provided by operations are sufficient to fund working capital requirements. The Company may need to incur additional liabilities with certain related parties to sustain the Company’s existence. There can be no assurance that the Company will be able to raise any additional capital and therefore raise doubt about the Company’s ability to continue as a going concern.

 

Future issuances of the Company’s equity or debt securities will be required for the Company to finance operations and continue as a going concern. The financial statements do not include any adjustments that may result from the outcome of these uncertainties.

 
v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION
 6 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

 

Principles of Consolidation and Basis of Presentation — The consolidated financial statements include the accounts of Graphene & Solar Technologies Limited and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). A summary of the significant accounting policies applied in the preparation of the accompanying financial statements can be found in the Company’s Annual Report in form 10-K for the year ended September 30, 2022.

 

Use of Estimates - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Significant estimates include but are not limited to the estimated useful lives of equipment for purposes of depreciation and the valuation of common shares issued for services, equipment and the liquidation of liabilities.

 

Cash and Cash Equivalents-Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments. As of March 31, 2023 and 2022, the Company had $10,349 and $4,196 in cash, respectively, and no cash equivalents.

 

Derivative Financial Instruments – The Company accounts for freestanding contracts that are settled in a company’s own stock, including common stock warrants, to be designated as an equity instrument or generally as a liability. A contract so designated is carried at fair value on a company’s balance sheet, with any changes in fair value recorded as a gain or loss in a company’s results of operations.

 

The Company records all derivatives on the balance sheet at fair value, adjusted at the end of each reporting period to reflect any material changes in fair value, with any such changes classified as changes in derivatives valuation in the statement of operations. The calculation of the fair value of derivatives utilizes highly subjective and theoretical assumptions that can materially affect fair values from period to period. The recognition of these derivative amounts does not have any impact on cash flows.

 

At the date of the conversion of any convertible debt, the pro rata fair value of the related embedded derivative liability is transferred to additional paid-in capital.

 

There was no derivative activity in fiscal quarter ending March 31, 2023. Therefore, no derivative liabilities were recorded during the quarter ended March 31, 2023.

 

Stock-Based Compensation -ASC 718, “Compensation - Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees and non-employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values on the grant date. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

 

During the quarter ended March 31, 2023, the Company issued 237,130 shares of the Company’s common stock.

 

Total stock-based compensation expense was $0 for the six-months ended March 31, 2023.

 

Foreign Currency Translations – The functional currency of the Company’s foreign subsidiary is primarily the respective local currency. Assets and liabilities of the Company’s foreign subsidiary are translated into U.S. Dollars at the year-end exchange rate, and revenues and expenses are translated at average monthly exchange rates. Translation gains and losses are recorded as a component of accumulated other comprehensive income (loss) within stockholders’ equity. All other foreign currency transaction gains and losses are included in other (income) expense, net.

 

Earnings Per Share - Basic earnings per share have been calculated based upon the weighted-average number of common shares outstanding. Diluted earnings per share were not calculated as such potential shares would be anti-dilutive.

 

Reclassifications - Certain amounts previously presented for prior periods have been reclassified to conform to the current presentation. The reclassifications had no effect on net loss, working capital or equity previously reported. 

 
v3.23.2
NOTES PAYABLE
 6 Months Ended
Mar. 31, 2023
Debt Disclosure [Abstract]  
NOTES PAYABLE

NOTE 3 – NOTES PAYABLE

 

The Company’s indebtedness as of March 31, 2023 and September 30, 2022 were as follows:

       
Description  March 31,
2023		  September 30, 2022
       
Convertible notes  $100,747   $100,747 
Notes Payable  $60,000   $76,255 
Notes Payable – Related Parties  $41,892   $—   

 

Notes Payable and Other Loans

 

During 2015 and 2016, the Company executed promissory notes payable with six individuals with an aggregate principal balance of $60,000. The notes were due on demand and included interest at 10%. As of March 31, 2023 and September 30, 2022, the total promissory notes payable balance was $105,701 and $99,701 including accrued interest of $45,701 and $39,701, respectively. On January 15, 2019, the holder of a note with a principal balance of $10,000 made demand for payment. To date, the note has not been paid.

 

During the year ended September 30, 2020 a Company Advisor, loaned the Company $5,781. The loan is a demand note at zero interest.

 

Convertible Notes Payable

 

As of March 31, 2023 and September 30, 2022, noteholders representing $70,747 in outstanding principal had not requested the exchange of shares of common stock. As of March 31, 2023 and September 30, 2022, the exchange obligation payable was $ 174,188.98 and $168,897.47 including accrued interest of $103,442 and $98,150, respectively. As of March 31, 2023 and September 30, 2022, the exchange obligation was for 52,625 shares and 51,026 shares of common stock, respectively.

 

On February 1, 2016, the Company issued convertible secured note payable of $30,000 to an individual. The note was due on January 31, 2017 and included interest at 10%. The note was convertible at discretion of the holder into common shares of the Company at the rate of $0.50 per shares. The Company has not extended the maturity date and the note is in default. As of March 31, 2023 and September 30, 2022, the total convertible note payable balance was $51,493 and $49,997, including accrued interest of $21,493 and $19,997 respectively. As of March 31, 2023 and September 30, 2022, the exchange obligation was for 102,986 shares and 99,994 shares of common stock, respectively.

 
v3.23.2
RELATED PARTY
 6 Months Ended
Mar. 31, 2023
Related Party Transactions [Abstract]  
RELATED PARTY

NOTE 4 – RELATED PARTY

 

CSA Liang Pty Ltd, a management company controlled by the Company’s Chief Executive Officer, and a Company Director, provides management services to the Company for which the Company is charged $20,833 monthly. During the three months ended March 31, 2023, the Company incurred charges to operations of $62,499 with respect to this arrangement.

 

On October 1, 2022, Mr. Andrew Liang signed a formal agreement with the Company to perform services of a Chief Executive Officer. Mr. Liang shall be issued 30,000,000 shares at the start of the contract. This is calculated as 10,000,000 shares for every year of this consulting agreement. Should the contract be terminated early, then the company has the right to purchase back a pro-rata portion of the 30,000,000 shares based on time served out of the 36-month contract. As of this filing date, the 30,000,000 shares have been approved but remain unissued.

 

On December 5, 2022, the Company entered into a Promissory Loan Note with Mr. Andrew Liang, in the amount of US$20,000, with a maturity date of December 5, 2023. The loan will accrue interest at the rate of 10% per annum.

 

On February 28, 2023, the Company entered into a Promissory Loan Note with MI Labs Pty Ltd, in the amount of US$50,000 (of which $21,892 was received by the company as of March 31, 2023) with a maturity date of February 28, 2024. The loan will accrue interest at the rate 10% per annum.

 

Mr. Thomas Chang was granted a maximum of 1,000,000 shares per annum subject to performance in fiscal years 2021/2022, 2022/2023 and 2023/2024 to a total of 3,000,000 shares. 1,000,000 shares were issued during the 2021/2022 fiscal year. As of this filing date, the remaining 2,000,000 shares have been approved but remain unissued.

 

During the quarters ended March 31, 2023 and 2022, stock-based compensation expense relating to directors, officers, affiliates and related parties was $0 (no shares) and $2,485,000 (3,500,000 shares), respectively.

 
v3.23.2
STOCKHOLDERS’ EQUITY
 6 Months Ended
Mar. 31, 2023
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 5 – STOCKHOLDERS’ EQUITY

 

237,130 new common shares were issued during the six- month period ending March 31, 2023 to settle accounts payable debt. The share prices at time of issuance was $0.2750, resulting in a loss on settlement of $40,441. 

 

The Company has a total of 5,778,366 shares that remain approved, reserved and outstanding and not yet issued by the Transfer Agent at March 31, 2023

 
v3.23.2
COMMITMENTS & CONTINGENCIES
 6 Months Ended
Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS & CONTINGENCIES

NOTE 6 – COMMITMENTS & CONTINGENCIES

 

Contingencies

 

From time to time, we may be involved in routine legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. The ultimate amount of liability, if any, for any claims of any type (either alone or in the aggregate) may materially and adversely affect our financial condition, results of operations and liquidity. In addition, the ultimate outcome of any litigation is uncertain. Any outcome, whether favorable or unfavorable, may materially and adversely affect us due to legal costs and expenses, diversion of management attention and other factors. We expense legal costs in the period incurred. We cannot assure you that additional contingencies of a legal nature or contingencies having legal aspects will not be asserted against us in the future, and these matters could relate to prior, current or future transactions or events. As of March 31, 2023, there were no pending or threatened litigation against the Company.

 
v3.23.2
INTANGIBLE ASSETS/PATENTS
 6 Months Ended
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS/PATENTS

NOTE 7 – INTANGIBLE ASSETS/PATENTS

 

We capitalize external costs, such as filing fees and associated attorney fees, incurred to obtain issued patents and patent license rights. We expense costs associated with maintaining and defending patents subsequent to their issuance in the period incurred. We amortize capitalized patent costs for internally generated patents on a straight-line basis for 7 years, which represents the estimated useful lives of the patents. The seven-year estimated useful life for internally generated patents is based on our assessment of such factors as: the integrated nature of the portfolios being licensed, the overall makeup of the portfolio over time, and the length of license agreements for such patents. The estimated useful lives of acquired patents and patent rights, however, have been and will continue to be based on a separate analysis related to each acquisition and may differ from the estimated useful lives of internally generated patents. The average estimated useful life of acquired patents is 6.7 years. We assess the potential impairment to all capitalized net patent costs when events or changes in circumstances indicate that the carrying amount of our patent portfolio may not be recoverable.

       
   March 30, 2023  March 30, 2022
Patents   1    6,879,745 
Accumulated amortization   —      (592,385)
Total patent costs, net   1    6,287,360 

 
v3.23.2
SUBSEQUENT EVENTS
 6 Months Ended
Mar. 31, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 8 – SUBSEQUENT EVENTS

 

On April 1, 2023, Mr. Jason May was appointed Chief Executive Officer by the Board of Directors. Mr. Andrew Liang has stepped down from the CEO role but remains a Director on the Board. Mr. May was granted 2,000,000 shares per the terms of the agreement. As of this filing date, the 2,000,000 shares have been approved but remain unissued.

 

On April 1, 2023, Mr. Charles Wantrup was appointed Corporate Secretary by the Board of Directors.

 

On April 1, 2023, Mr. Arnold Sock signed a services agreement with the Company and was issued 5,000,000 shares per the terms of the agreement.

 

On April 12, 2023, Mr. Raymond Purdon signed a consulting agreement with the Company and was issued 5,000,000 shares per the terms of the agreement.

 

On April 27, 2023, Brookside Communications signed a consulting agreement with the Company and was issued 250,000 shares per the terms of the agreement.

 

The Company has evaluated events occurring subsequent to March 31, 2023 through to the date these financial statements were issued and has identified no additional events requiring disclosure.
v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION (Policies)
 6 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Principles of Consolidation and Basis of Presentation

Principles of Consolidation and Basis of Presentation — The consolidated financial statements include the accounts of Graphene & Solar Technologies Limited and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). A summary of the significant accounting policies applied in the preparation of the accompanying financial statements can be found in the Company’s Annual Report in form 10-K for the year ended September 30, 2022.

 
Use of Estimates

Use of Estimates - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Significant estimates include but are not limited to the estimated useful lives of equipment for purposes of depreciation and the valuation of common shares issued for services, equipment and the liquidation of liabilities.

 
Cash and Cash Equivalents

Cash and Cash Equivalents-Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments. As of March 31, 2023 and 2022, the Company had $10,349 and $4,196 in cash, respectively, and no cash equivalents.

 
Derivative Financial Instruments

Derivative Financial Instruments – The Company accounts for freestanding contracts that are settled in a company’s own stock, including common stock warrants, to be designated as an equity instrument or generally as a liability. A contract so designated is carried at fair value on a company’s balance sheet, with any changes in fair value recorded as a gain or loss in a company’s results of operations.

 

The Company records all derivatives on the balance sheet at fair value, adjusted at the end of each reporting period to reflect any material changes in fair value, with any such changes classified as changes in derivatives valuation in the statement of operations. The calculation of the fair value of derivatives utilizes highly subjective and theoretical assumptions that can materially affect fair values from period to period. The recognition of these derivative amounts does not have any impact on cash flows.

 

At the date of the conversion of any convertible debt, the pro rata fair value of the related embedded derivative liability is transferred to additional paid-in capital.

 

There was no derivative activity in fiscal quarter ending March 31, 2023. Therefore, no derivative liabilities were recorded during the quarter ended March 31, 2023.

 
Stock-Based Compensation

Stock-Based Compensation -ASC 718, “Compensation - Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees and non-employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values on the grant date. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

 

During the quarter ended March 31, 2023, the Company issued 237,130 shares of the Company’s common stock.

 

Total stock-based compensation expense was $0 for the six-months ended March 31, 2023.

 
Foreign Currency Translations

Foreign Currency Translations – The functional currency of the Company’s foreign subsidiary is primarily the respective local currency. Assets and liabilities of the Company’s foreign subsidiary are translated into U.S. Dollars at the year-end exchange rate, and revenues and expenses are translated at average monthly exchange rates. Translation gains and losses are recorded as a component of accumulated other comprehensive income (loss) within stockholders’ equity. All other foreign currency transaction gains and losses are included in other (income) expense, net.

 
Earnings Per Share

Earnings Per Share - Basic earnings per share have been calculated based upon the weighted-average number of common shares outstanding. Diluted earnings per share were not calculated as such potential shares would be anti-dilutive.

 
Reclassifications

Reclassifications - Certain amounts previously presented for prior periods have been reclassified to conform to the current presentation. The reclassifications had no effect on net loss, working capital or equity previously reported. 
v3.23.2
NOTES PAYABLE (Tables)
 6 Months Ended
Mar. 31, 2023
Debt Disclosure [Abstract]  
Schedule of notes payable
       
Description  March 31,
2023		  September 30, 2022
       
Convertible notes  $100,747   $100,747 
Notes Payable  $60,000   $76,255 
Notes Payable – Related Parties  $41,892   $—   
v3.23.2
INTANGIBLE ASSETS/PATENTS (Tables)
 6 Months Ended
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of finite lived intangible assets

       
   March 30, 2023  March 30, 2022
Patents   1    6,879,745 
Accumulated amortization   —      (592,385)
Total patent costs, net   1    6,287,360 
v3.23.2
BASIS OF PRESENTATION (Details Narrative)
 153 Months Ended
Mar. 31, 2023
USD ($)
Accounting Policies [Abstract]  
Net losses $ 67,446,376
v3.23.2
Schedule of notes payable (Details) - USD ($)
Mar. 31, 2023
Sep. 30, 2022
Debt Disclosure [Abstract]    
Convertible notes $ 100,747 $ 100,747
Notes Payable 60,000 76,255
Notes Payable – Related Parties $ 41,892
v3.23.2
Schedule of finite lived intangible assets (Details) - USD ($)
Mar. 30, 2023
Mar. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]    
Patents $ 1 $ 6,879,745
Accumulated amortization (592,385)
Total patent costs, net $ 1 $ 6,287,360
Graphene and Solar Techn... (PK) (USOTC:GSTX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Graphene and Solar Techn... (PK) Charts.
Graphene and Solar Techn... (PK) (USOTC:GSTX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Graphene and Solar Techn... (PK) Charts.